0 Commentaires
0 Parts
2166 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Asia Pacific Chordoma Disease Market: Government Support for Rare Disease Management - Forecast - 2032North America: The North America Chordoma Disease Market is primarily driven by the presence of advanced healthcare systems and a high incidence rate of chordoma cases, particularly in the United States. Access to modern treatment options such as surgery, radiation therapy, and targeted therapies contributes to market growth in the region. Research initiatives and clinical trials in...0 Commentaires 0 Parts 109 Vue 0 Aperçu
- Asia Pacific Mitochondrial Myopathies Market: Rising Awareness and Investment in Rare Disease Treatment - Forecast - 2032North America The mitochondrial myopathies market in North America is experiencing substantial growth, driven by the increasing prevalence of mitochondrial diseases and advancements in genetic testing and treatment options. The United States and Canada, with their advanced healthcare infrastructure, are key players in this market. The rising awareness of rare diseases, coupled with ongoing...0 Commentaires 0 Parts 117 Vue 0 Aperçu
- Asia Pacific Parry-Romberg Syndrome Market: Rising Focus on Rare Disease Management - Forecast - 2032North America The Parry-Romberg Syndrome market in North America is witnessing gradual growth due to the increasing awareness of the condition and advancements in diagnostic techniques. The United States, with its advanced healthcare infrastructure, leads the market, driven by a growing number of reported cases and a focus on personalized treatment options. Canada is also seeing an uptick in...0 Commentaires 0 Parts 143 Vue 0 Aperçu
- Asia Pacific Parry-Romberg Syndrome Market: Rising Focus on Rare Disease Management - Forecast - 2032North America The Parry-Romberg Syndrome market in North America is witnessing gradual growth due to the increasing awareness of the condition and advancements in diagnostic techniques. The United States, with its advanced healthcare infrastructure, leads the market, driven by a growing number of reported cases and a focus on personalized treatment options. Canada is also seeing an uptick in...0 Commentaires 0 Parts 127 Vue 0 Aperçu
- Carglumic Acid Market: An Emerging Segment in Rare Disease TreatmentIntroduction Carglumic acid is stated as an orphan drug that's mainly used to treat hyperammonemia, also called NAGS Syndrome. This rare genetic defect happens primarily thanks to a lack of an enzyme called N-acetyl glutamate synthase (NAGS) within the liver. This results in increased levels of ammonia within the blood. Several neurological disorders like hepatic encephalopathy, congenital...0 Commentaires 0 Parts 147 Vue 0 Aperçu
- Europe Rare Disease Diagnostics Market Size and Share: In-Depth Analysis and Forecast 2024-2032Market Overview: The newly published research report titled Europe Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type, By Product Type, By Sample Type, By Technology, By Test, By Age Group, By Trait Type, By End-User, By Country; Segment Forecast, 2024 - 2032 is a vital resource to understand the dynamics of the rapidly growing sector....0 Commentaires 0 Parts 436 Vue 0 Aperçu
- Gene Therapy for Rare Disease is Estimated to Witness High Growth Owing to Rising Prevalence of Rare DiseasesGene therapy involves the delivery of corrective genes to treat rare diseases caused by missing or defective genes. It has shown great potential in the treatment of inherited disorders like hemophilia, cystic fibrosis, and muscular dystrophy. These therapies aim to either introduce a normal copy of the defective gene or inactivate a mutated gene that is responsible for causing the disease. As...0 Commentaires 0 Parts 1362 Vue 0 Aperçu
- Gene Therapy for Rare Disease Market Is Driven by Growing Incidence of Rare DiseasesGene therapy has emerged as a promising approach for treating rare diseases by repairing or replacing a mutated gene responsible for a genetic disorder. Gene therapy involves modifying genes or introducing foreign genes into cells and tissues to treat disease. It aims to compensate for abnormal genes that cause genetic disorders by delivering normal genes to replace or supplement missing or...0 Commentaires 0 Parts 775 Vue 0 Aperçu
- Gene Therapy For Rare Disease Market Is Driven By Rising Prevalence Of Rare DiseasesThe gene therapy for rare disease market involves the therapeutic delivery of nucleic acids into patient's cells and tissues to treat a variety of medical conditions. Gene therapy or gene transfer aims at manipulation of an individual's genes through altering, adding or knocking out a gene to treat a disease. For rare diseases, gene therapy involves administering functional genes to diseased...0 Commentaires 0 Parts 1323 Vue 0 Aperçu
- Advances in Duchenne Muscular Dystrophy TreatmentCauses and Mechanism of Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by the absence of dystrophin, a protein that helps keep muscle cells intact. The defective gene that causes DMD is located on the X chromosome, so it primarily affects boys. Girls can be carriers of the defective...0 Commentaires 0 Parts 842 Vue 0 Aperçu
- Exploring the Landscape of Leigh Syndrome Treatment: Insights and ConsiderationsLeigh Syndrome Treatment encompasses a diverse array of approaches aimed at managing the symptoms and complications associated with this rare and debilitating neurological disorder. With Leigh Syndrome being a genetic condition characterized by mitochondrial dysfunction, treatment strategies focus on alleviating symptoms, improving quality of life, and addressing the underlying molecular...0 Commentaires 0 Parts 1253 Vue 0 Aperçu
- Gene Therapy For Rare Disease Market Is Driven By Rising Prevalence Of Rare DiseasesThe gene therapy for rare disease market involves the therapeutic delivery of nucleic acids into patient's cells and tissues to treat a variety of medical conditions. Gene therapy or gene transfer aims at manipulation of an individual's genes through altering, adding or knocking out a gene to treat a disease. For rare diseases, gene therapy involves administering functional genes to diseased...0 Commentaires 0 Parts 1306 Vue 0 Aperçu
- Gene Therapy Market is Estimated to Witness High Growth Owing to Rising Prevalence of Genetic DisordersGene therapy is a type of treatment that involves the modification of genes or genetic material to treat or cure disease. Diseases that gene therapy aims to cure include inherited disorders, various types of cancer, and certain viral infections. Gene therapy typically works by inserting a normal gene to replace the abnormal gene responsible for the disease. Gene therapy holds the potential to...0 Commentaires 0 Parts 1223 Vue 0 Aperçu
- Global Gene Therapy for Rare Disease Market Is Estimated To Witness High Growth Owing To Technological Advancements and Increasing Investments in R&DThe Gene Therapy for Rare Disease Market is estimated to be valued at US$ 16.3 million in 2017 and is expected to exhibit a CAGR of 35.0% over the forecast period 2018–2026, as highlighted in a new report published by Coherent Market Insights.Market Overview:Gene therapy refers to the introduction of genetic material into the cells of a patient to treat or prevent rare genetic diseases....0 Commentaires 0 Parts 1806 Vue 0 Aperçu
Plus de résultats